Develops bioengineered human tissues for vascular repair and reconstruction.
Jun 2026Revenue $2.12M/yrExpenses $113M/yr
No trendCash runway ≈ 10 months from Jun 2026
Figures by year
When will Humacyte be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $2.12M and expenses $113M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.04M | $110M | −$108M |
| Dec 2024 | $0.00 | $114M | −$114M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.